What is Neuropace, Inc.'s net margin?

Neuropace, Inc. (NPCE) reported net margin of -21.7% in Q1 2026.

How has Neuropace, Inc.'s net margin changed year-over-year?

Neuropace, Inc.'s net margin increased by 26.4% year-over-year, from -29.4% to -21.7%.

What is the long-term trend for Neuropace, Inc.'s net margin?

Over 5 years (2020 to 2025), Neuropace, Inc.'s net margin has grown at a -18.3% compound annual growth rate (CAGR), from -59% to -21.5%.

What does net margin mean?

Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.

Neuropace, Inc. NPCE Net margin

Net margin at other companies

MedtronicMDT

13.2%-0.7pp

LivaNovaLIVN

-16.1%-18.0pp

ClearPoint NeuroCLPT

-71.6%+8.8pp

Inspire Medical SystemsINSP

14.3%+6.4pp

ARS Pharmaceuticals, Inc.SPRY

-200%-219pp

Catalyst PharmaceuticalCPRX

37.1%+0.2pp

Other financials

Income statement

See full

Revenue$22.1M-2.0%

Gross profit$18.0M+4.1%

Operating income-$5.6M-8.2%

Net income-$6.7M-1.5%

EPS (diluted)-$0.20+4.8%

Balance sheet

See full

Cash & equivalents$15.6M-42.4%

Total debt$70.5M-3.7%

Total equity$14.5M-40.4%

Total assets$98.9M-10.3%

Cash flow

See full

Operating cash flow-$5.9M+21.1%

CapEx$117.0K+216%

Free cash flow-$6.0M+20.0%

Valuation

See full

Market cap$557.77M+63.4%

Enterprise value$612.6M+58.1%

P/S5.6×+1.6×

Profitability

See full

Gross margin78.3%+3.5pp

Operating margin-16.8%-3.5pp

FCF margin-10.3%-3.5pp

Returns & leverage

See full

Return on equity-111.4%-13.1pp

Debt / equity4.9×+1.9×

Current ratio5.4×-1.2×

Where this comes from

Calculated from Neuropace, Inc.’s reported figures.

net income/total revenue=-21.7%

Based on trailing twelve months.

The official record: Neuropace, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neuropace, Inc.'s net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Neuropace, Inc.'s net margin?: Neuropace, Inc. (NPCE) reported net margin of -21.7% in Q1 2026.
How has Neuropace, Inc.'s net margin changed year-over-year?: Neuropace, Inc.'s net margin increased by 26.4% year-over-year, from -29.4% to -21.7%.
What is the long-term trend for Neuropace, Inc.'s net margin?: Over 5 years (2020 to 2025), Neuropace, Inc.'s net margin has grown at a -18.3% compound annual growth rate (CAGR), from -59% to -21.5%.
What does net margin mean?: Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.